niceritrol has been researched along with Thrombopenia in 1 studies
Niceritrol: An ester of nicotinic acid that lowers cholesterol and triglycerides in total plasma and in the VLD- and LD-lipoprotein fractions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wakasugi, H | 1 |
| Futami, T | 1 |
| Muso, E | 1 |
| Ono, T | 1 |
| Sasayama, S | 1 |
| Inui, K | 1 |
1 other study available for niceritrol and Thrombopenia
| Article | Year |
|---|---|
Thrombocytopenia and anemia induced by niceritrol used for amelioration of hyperphosphatemia in a hemodialysis patient.
Topics: Anemia; Female; Humans; Hypolipidemic Agents; Kidney Failure, Chronic; Middle Aged; Niceritrol; Phos | 2000 |